Probiotic Didn’t Boost H. Pylori Cure Rates, But It Fixed a Bigger Problem

If you or your teenager has ever been prescribed a week of antibiotics to clear a stomach infection, you already know the hard part isn't the diagnosis, it's finishing the pills without quitting halfway through because your stomach hurts. A new study out of Japan looked at whether adding a common probiotic to that regimen helps, and the answer is more nuanced than a simple yes. It didn't meaningfully raise the odds of curing the infection, but it did something that may matter just as much: it kept far more teenagers on their medication until the end.

Key takeaways:

• In 1,169 adolescents treated for Helicobacter pylori (H. pylori, a stomach bacterium linked to ulcers and gastric cancer), adding the probiotic Clostridium butyricum did not significantly raise first-line cure rates (85.0% with probiotic vs 73.3% without, P = 0.216).
• What did significantly improve: treatment completion. 100% of teens on the higher probiotic dose finished all 14 prescribed doses, versus 92.0% of those who got no probiotic (P = 0.0048).
• The probiotic caused no extra diarrhea, abdominal pain, or stool changes, so the adherence gain came without a safety tradeoff.
• This was a retrospective, real-world cohort, not a randomized trial, and the no-probiotic comparison group was small (30 teens), so the eradication numbers should be read as suggestive, not proven.

Clostridium Butyricum Added to Standard Therapy in Large Teen Cohort

Researchers led by Toshihiko Kakiuchi at Saga University tracked 1,169 adolescents who tested positive for H. pylori through a school-based screening program in Saga Prefecture, Japan, between 2016 and 2025. All of them received the same standard first-line treatment, a week of three drugs (vonoprazan, amoxicillin, and clarithromycin) known as triple therapy. On top of that, some received an oral probiotic supplement called Miya-BM, made from Clostridium butyricum, a bacterium that produces butyrate (a short-chain fatty acid gut cells use as fuel and that helps regulate inflammation). Depending on which clinic they attended and when, teens got zero, four, or six tablets of the probiotic per day alongside their antibiotics. The study, published as a preprint on Research Square, compared how each group fared.

Stomach Infection Tied to Ulcers and Gastric Cancer Risk in Teens

H. pylori is a spiral-shaped bacterium that infects the stomach lining and, left untreated, is a well-established cause of chronic gastritis, peptic ulcers, and gastric cancer, one of the leading causes of cancer death worldwide. It's typically caught in childhood and persists for life unless eradicated, which is why Japan runs school screening programs like the one this study drew from, aiming to clear the infection in adolescence before any lasting damage to the stomach lining sets in. The catch is that eradication therapy itself can be miserable to sit through: the antibiotic combination frequently causes diarrhea and abdominal pain, and when kids feel sick enough, they stop taking their pills, which lets the infection survive and, worse, breeds antibiotic-resistant bacteria.

Retrospective Design Traded Randomization for a Real-World Sample of Over 1,100 Patients

This was not a randomized controlled trial. It was a retrospective, multicenter cohort study, meaning researchers pulled medical records after the fact rather than assigning treatment in a controlled experiment. That matters because a study like this is inherently more vulnerable to bias than a randomized trial. But the authors point out one specific strength: which teens got the probiotic and at what dose was decided by each clinic's standard protocol and how that protocol changed over time, not by individual doctors picking healthier or sicker patients to receive it. That reduces (though doesn't eliminate) the risk that the probiotic group looked better simply because they were an easier population to begin with. The tradeoff for that real-world scale, over 1,100 adolescents, was a lopsided comparison: only 30 teens received no probiotic at all, versus 838 on the four-tablet dose and 301 on the six-tablet dose, which limits how confidently the eradication-rate difference can be interpreted.

What the Adherence Finding Means if You're Weighing a Probiotic Alongside Antibiotics

The study's most concrete, statistically solid finding isn't about killing bacteria, it's about staying the course. Teens on the probiotic were significantly more likely to complete their full 14-dose antibiotic regimen than those who weren't, and they did it without any measurable increase in diarrhea, abdominal pain, or other gut side effects. For a parent or patient weighing whether to add a probiotic during antibiotic treatment, that's the honest takeaway here: this isn't evidence that C. butyricum cures the infection more often, but it is evidence, in a large real-world sample, that it's safe and may make it easier to actually finish the antibiotics as prescribed. Anyone considering it should still raise it with their doctor rather than self-prescribing, since guideline bodies have not endorsed any specific probiotic as standard care.

Eradication-Rate Gap Did Not Reach Statistical Significance

Here's the caveat that matters most: the headline number, that eradication rates were 85.0% with the probiotic versus 73.3% without, looks like a meaningful 12-percentage-point gap. But the study's own statistics say that gap could plausibly be due to chance, since the difference did not reach statistical significance (P = 0.216). The small size of the no-probiotic group (just 30 patients) makes this comparison underpowered, meaning the study wasn't equipped to detect a real difference even if one exists. The researchers also ran pairwise comparisons and a trend test across doses, and none crossed the threshold for statistical significance. Current pediatric guidelines from ESPGHAN and NASPGHAN, the major European and North American pediatric gastroenterology bodies, still do not recommend routine probiotic use during H. pylori eradication in children and adolescents, citing exactly this kind of inconsistent, not-yet-conclusive evidence across studies and probiotic strains.

Randomized Trials Needed to Confirm Whether the Trend Is Real

The authors are explicit that this retrospective result is not the final word. They call for prospective, randomized controlled trials, the gold-standard study design where patients are randomly assigned to probiotic or no probiotic, to determine whether the numerically higher eradication rates seen here reflect a genuine effect or a fluke of an unevenly sized comparison group. Until then, this study adds one large, safety-reassuring data point to a body of evidence on probiotics and H. pylori that remains genuinely mixed: some meta-analyses of randomized trials in children have found probiotics modestly improve both eradication success and antibiotic-related side effects, while others, including the guideline reviewers, judge the evidence too inconsistent across probiotic strains to recommend routine use.

Common Questions

Does this mean probiotics cure H. pylori? No. The eradication-rate difference in this study was not statistically significant, so it cannot be treated as proof the probiotic clears the infection more often.

Is Clostridium butyricum (Miya-BM) safe to take with antibiotics? In this study, yes, it caused no measurable increase in diarrhea, abdominal pain, or other gut symptoms compared to no probiotic. But this was one observational study, not a safety trial, and it doesn't apply to every probiotic strain or supplement.

Why does treatment adherence matter so much for H. pylori? Because the antibiotic combination only works if it's taken in full. Stopping early lets the bacteria survive and can contribute to antibiotic resistance, which is already making H. pylori harder to treat worldwide.

Should I ask my doctor about adding a probiotic during H. pylori treatment? It's a reasonable question to raise, especially if antibiotic side effects are a concern, but major pediatric guidelines don't currently recommend any specific probiotic as standard practice, so it should be a conversation with a doctor, not a self-directed decision.

References

Toshihiko Kakiuchi, Hiroyoshi Endo, Takahiro Noda, et al. (2026). Association of adjunctive Clostridium butyricum supplementation with eradication outcomes and safety during Helicobacter pylori eradication therapy in adolescents: A multicenter retrospective cohort study. https://doi.org/10.21203/rs.3.rs-10553599/v1